News | October 23, 2023
Indoco Remedies posts consolidated Q2FY24 PAT at Rs. 35.08 Cr
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
The company has reported total income of Rs. 486.16 crores during the period ended September 30, 2023
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
Profit after tax (before exceptional items) up 23% to Rs 215 crores
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
